Vitamin B12 may shape metabolism and aging more than previously understood. Vitamin B12 is typically associated with red ...

Folic acid, the synthetic form of vitamin B9, is a quiet hero in reproductive health, especially for women planning or capable of pregnancy. It plays a vital role in preventing neural tube defects, ...

A major shift is coming to the snack aisle as state lawmakers move to close a decades-old gap in American nutrition. In January, California became the first state to require large manufacturers to add ...

The FDA made waves with its recent announcement that a single well-controlled Phase 3 study would suffice for a drug submission, replacing the previous standard of two pivotal studies. This past week, ...

Share on Pinterest More research is still needed before leucovorin should be approved as an autism treatment. Westend61/Getty Images Federal regulators have approved leucovorin for the treatment of ...

The approval was supported by a systematic review of published literature that included 46 patients with FOLR1-CFTD treated with leucovorin through various administration routes. The Food and Drug ...

What Is It, and Why Does It Matter? Wellcovorin (leucovorin calcium) is a type of folate your body can use. In case reports of people with folate receptor 1‑related cerebral folate transport ...

The FDA’s actions have been unusual from the start of this leucovorin saga. The decades-old drug is often used to help cancer patients fight side effects of chemotherapy and other treatments that ...

The Food and Drug Administration approved a decades-old prescription vitamin called leucovorin as the first treatment for a rare genetic disorder in certain adults and children. The move comes months ...

March 10 (UPI) --The Food and Drug Administration has approved expanded use of leucovorin calcium tablets for treating cerebral folate deficiency, a rare disorder. The vitamin, a synthetic form of ...

Please provide your email address to receive an email when new articles are posted on . The approval targets patients with a folate receptor 1 gene variant. The American Academy of Pediatrics does not ...